Mount Sinai researchers have fundamentally reshaped the scientific understanding of Alzheimer’s disease by uncovering how the APOE4 gene—the most significant…
Read More
Unlocking the 3D Genome: A New Frontier in Understanding Alzheimer’s Disease Pathogenesis
A collaborative team of researchers from Carnegie Mellon University (CMU), the University of Pittsburgh (Pitt), and the University of Washington…
Read More
Gut-Derived Molecule Imidazole Propionate Identified as Potential Catalyst for Alzheimer’s Disease Progression and Cognitive Decline
A growing body of medical research has increasingly pointed toward the human digestive tract as a vital, albeit complex, player…
Read More
Newer blood thinners linked to slower cognitive decline in Alzheimer’s patients with atrial fibrillation
The medical community has long grappled with the complex intersection of cardiovascular health and neurodegenerative disease, particularly regarding the management…
Read More
Mount Sinai Researchers Uncover How APOE4 Drives Alzheimer’s and Neurodegeneration Through Vascular and Metabolic Disruption
In a significant breakthrough for the field of neurobiology, researchers at the Icahn School of Medicine at Mount Sinai have…
Read More
New Research Identifies Peripheral Immune Pathway as a Critical Driver of Alzheimer’s Disease Neurodegeneration
For decades, the prevailing consensus in neurology characterized Alzheimer’s disease as an inherently localized phenomenon, a process of protein misfolding…
Read More
New insights into Alzheimer’s disease emerge as researchers map the three-dimensional architecture of the genome within the human brain.
For decades, the global scientific consensus on the pathology of Alzheimer’s disease has been dominated by two primary suspects: the…
Read More
Newer blood thinners linked to slower cognitive decline in patients with atrial fibrillation and Alzheimer’s disease
A landmark study conducted by researchers at the Karolinska Institutet in Sweden has unveiled promising evidence that the use of…
Read More
A New Dimension of Alzheimer’s Disease: Researchers Uncover Genome Folding Defects as a Key Driver of Neurological Decline
For decades, the global scientific community’s understanding of Alzheimer’s disease has been anchored to the "amyloid hypothesis"—the observation that the…
Read More
Newer NOAC Blood Thinners Linked to Slower Cognitive Decline in Patients with Atrial Fibrillation and Alzheimer’s Disease
The intersection of cardiovascular health and neurodegenerative disease has long been a focal point of clinical research, particularly as global…
Read MoreYOU MAY HAVE MISSED
